[Hong Kong, 4 March 2016] Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI) has announced the appointment of Mr Andy Liu, Vice Chairman of Hong Kong Biotechnology Organization, to the ASTRI Board for a term of two years with effect from 1 March 2016.
Mr Andy Liu has served as President of Asia Pacific and China for IMS Health, a TPG private equity portfolio company focusing on big data healthcare. Mr Liu’s area of focus is commercialisation and M&A. He has extensive experience in healthcare big data and healthcare technologies.
Furthermore, commencing 1 March 2016, three serving Directors of ASTRI, namely Mr Cheng Cheuk-wing, Prof Ching Pak-chung and Mr Ha Yung-kuen have also been re-appointed for another two-year term.
[Hong Kong, 23 September 2021] The Hong Kong Applied Science and Technology Research Institute (ASTRI) has today announced the appointment of Dr. Denis Shing Fai …
ASTRI recently received a letter of thanks from Taiwan’s National Communications Commission (NCC) for helping solve the problem of 5G communications interference. The 3.5 GHz …
The “Flexible Integration of Recognition and Semantic” project, led by Dr Arvin Tang, has won Gold Award in the Asia International Innovative Invention Award 2019. …
The Hong Kong Applied Science and Technology Research Institute (ASTRI) is showcasing its latest technologies at the China Hi-Tech Fair (CHTF) 2019 in Shenzhen. ASTRI’s cutting-edge …
ASTRI has unveiled at VR EXPO 2019, the largest industry expo in South Korea, a reference design for production-ready 4Kx2K augmented reality (AR) Head Mounted …
Hong Kong Applied Science and Technology Research Institute (ASTRI) was founded by the Government of the Hong Kong Special Administrative Region in 2000 with the mission of enhancing Hong Kong’s competitiveness through applied research. ASTRI’s core R&D competence in various areas is grouped under five Technology Divisions: Advanced Electronic Components and Systems; Artificial Intelligence and Trust Technologies; Communications Technologies; IoT Sensing and AI Technologies; and Intelligent Perception and Control Technologies. It is applied across six core areas which are Smart City, Financial Technologies, New Industrialisation and Intelligent Manufacturing, Digital Health, Application Specific Integrated Circuits and Metaverse.
Over the years, ASTRI has nurtured a pool of research, I&T talents and received numerous international awards for its pioneering innovations as well as outstanding business and community contributions. ASTRI has transferred about 1,600 technologies to the industry and has been granted close to 1,200 patents in the Mainland, the United States, and other countries.
As a Hong Kong R&D centre, one of ASTRI’s important goals is to help customers harness business opportunities from the thriving technology market and increase their competitive strengths. Customers and partners can improve their efficacy by drawing on ASTRI’s expertise and research achievements.